I kliniske afprøvninger med administration af 7350 doser PROCOMVAX til 2993 raske spædbørn i alderen 6 uger til 15 måneder, blev der i almindelighed vist god tolerance.
In clinical trials involving the administration of 7,350 doses of PROCOMVAX to 2,993 healthy infants 6 weeks to 15 months of age, PROCOMVAX was generally well tolerated.